CJC-1295 (without DAC) and Metformin Interaction
CJC-1295 (without DAC) and Metformin have a synergistic interaction with 51% confidence. CJC-1295 (without DAC) helps counteract the insulin-disrupting effects of Metformin. A smart combination — the insulin sensitizer mitigates metabolic side effects. These compounds primarily affect different organ systems.
Compound Profiles
CJC-1295 (without DAC)
Short-Acting Growth Hormone Releasing Hormone Analog
Binds GHRH receptors on somatotroph cells in the pituitary gland, stimulating cAMP production and physiological GH pulses. The brief 30-minute half-life allows pulsatile release versus prolonged elevation.
View full profileMetformin
Biguanide | AMPK Activator & Longevity Research
Metformin exerts its primary effects through activation of AMP-activated protein kinase (AMPK), the cell's master energy sensor. AMPK activation triggers a cascade of downstream metabolic improvements: enhanced glucose uptake in skeletal muscle, suppression of hepatic gluconeogenesis, improved mitochondrial function, and increased fatty acid oxidation.
View full profileCombined Organ Load
Frequently Asked Questions
Can I take CJC-1295 (without DAC) with Metformin?
Yes, CJC-1295 (without DAC) and Metformin can generally be taken together. CJC-1295 (without DAC) helps counteract the insulin-disrupting effects of Metformin. A smart combination — the insulin sensitizer mitigates metabolic side effects.
Is CJC-1295 (without DAC) and Metformin safe together?
Based on pharmacological analysis, this combination is considered synergistic. No critical safety flags identified for this pair.
What are the interactions between CJC-1295 (without DAC) and Metformin?
CJC-1295 (without DAC) helps counteract the insulin-disrupting effects of Metformin. A smart combination — the insulin sensitizer mitigates metabolic side effects. This assessment has 51% confidence and is inferred from pharmacological mechanism analysis.
How should I time CJC-1295 (without DAC) and Metformin?
CJC-1295 (without DAC) has a half-life of 30 minutes - 2 hours and Metformin has a half-life of ~5 hours. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.
This interaction analysis is compiled from research literature and pharmacological mechanism data. This assessment is inferred from known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.